← Back to Patent Explorer
US4413012A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for treating depression

Assignee: Merrell Toraude et Cie
•
Filing: 1982-05-26
•
Granted: 1983-11-01
•
Expires: 2002-05-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2-Amino-3-(3'-hydroxyphenyl)-3-butenoic acid or 2-amino-3-(3', 4'-dihydroxyphenyl)-3-butenoic acid can be used to treat depression either alone or in combination with an extracerebrally acting AADC inhibitor.

Inventors

  • 👤 Michael G. Palfreyman
  • 👤 Ian A. McDonald

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 12:54
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195; C; C07; C07D; C07D309/00; C07D309/02; C07D309/08; C07D309/10; C07D309/12

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 90 words
A method for treating depression which comprises administering to a depressed patient an antidepressant effective amount of 2-amino-3-(3'-hydroxyphenyl)-3-butenoic acid or 2-amino-3-(3',4'-dimethoxyphenyl)-3-butenoic acid, or a (C 1 -C 8 ) alkyl ester thereof or a pharmaceutically acceptable salt thereof; in combination with an AADC inhibitor selected from carbidopa, benserazide, or a 2-amino-3-(monofluoromethyl or difluoromethyl)-3-(monohydroxyphenyl or dihydroxyphenyl)-propionic acid, the amount of said AADC inhibitor being effective to substantially block the AADC catalyzed decarboxylation of said antidepressant compound extracerebrally without substantially blocking the AADC catalyzed decarboxylation of said antidepressant compound in the brain.
Claim 2
Independent Claim 90 words
A method for treating depression which comprises administering to a depressed patient an antidepressant effective amount of 2-amino-3-(3'-hydroxyphenyl)-3-butenoic acid or 2-amino-3-(3',4'-dimethoxyphenyl)-3-butenoic acid, or a (C 1 -C 8 ) alkyl ester thereof or a pharmaceutically acceptable salt thereof; in combination with an AADC inhibitor selected from carbidopa, benserazide, or a 2-amino-3-(monofluoromethyl or difluoromethyl)-3-(monohydroxyphenyl or dihydroxyphenyl)-propionic acid, the amount of said AADC inhibitor being effective to substantially block the AADC catalyzed decarboxylation of said antidepressant compound extracerebrally without substantially blocking the AADC catalyzed decarboxylation of said antidepressant compound in the brain.
Claim 3
Dependent Claim 14 words
A method as defined in claim 1 wherein the compound administered is 2-amino-3-(3'-hydroxyphenyl)-3-butenoic acid.
Claim 4
Dependent Claim 14 words
A method as defined in claim 1 wherein the compound administered is 2-amino-3-(3',4'-dihydroxyphenyl)-3-butenoic acid.
Claim 5
Dependent Claim 13 words
A method as defined in claim 1 wherein the AADC inhibitor is carbidopa.
Claim 6
Dependent Claim 13 words
A method as defined in claim 1 wherein the AADC inhibitor is benserazide.
Claim 7
Dependent Claim 19 words
A method as defined in claim 1 wherein the AADC inhibitor is a 2-amino-2-(monofluoromethyl or difluoromethyl)-3-(monohydroxyphenyl or dihydroxyphenyl)propionic acid.
Claim 8
Dependent Claim 24 words
A method as defined in claim 6 wherein the AADC inhibitor is 2-amino-2-fluoromethyl-3-(3',4'-dihydroxyphenyl)propionic acid or 2-amino-2-difluoromethyl-3-(3',4'-dihydroxyphenyl)propionic acid, or a 2',3'- or 2',5'-dihydroxyphenyl isomer thereof.
Claim 9
Dependent Claim 18 words
A method as claimed in claim 4, 5, 6, or 7 wherein the compound administered is 2-amino-3-(3'-hydroxyphenyl)-3-butenoic acid.
Claim 10
Dependent Claim 18 words
A method as defined in claim 4, 5, 6, or 7 wherein the compound administered is 2-amino-3-(3',4'-dihydroxyphenyl)-3-butenoic acid.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-10-31 1987-05-02 1987-11-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-10-31 1991-05-02 1991-11-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-10-31 1995-05-02 1995-11-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag